Delivering on the promise requires action on five strategic and operational tracks.
Through carve-outs, companies can create value, streamline portfolios, and reduce complexity. But the ultimate success of a deal hinges on focused, proactive execution.
Powerful new models are in the works, but effective implementation depends on building the right capabilities and enablers.
By transforming their commercial operating model, biopharma companies can better engage with health care professionals and patients.
These essential actions weave digital capabilities into each phase of the launch journey.
BCG’s latest survey on the impact of COVID-19 shows which changes in how doctors engage with the pharma industry will last beyond the pandemic.
As competition grows, plans need to win their members’ trust—and their renewal—every year. Here’s how to do it.
The transformation agenda for health care is government-led, tailored to your country's capabilities, and focused on better outcomes. Use this domains-and-roles framework to set your health care systems on track.
What challenges does the future hold for a fast-evolving sector that has undergone decades of change in the past 18 months?
For health insurance payers, success in Medicare Advantage depends on the stars.
A global leader in prostheses, Ottobock set out to also become the ESG leader in its field. The key: measuring the socioeconomic benefit of its products.
When patients move through hospital units—and eventually are discharged—their vital information doesn’t follow. But smarter solutions can track patient data across settings.
A sea change is underway in how companies win regulatory approval for new health care products—particularly in the use of digital technology—and which markets they prioritize.
As the current crisis demonstrates, biopharma and medtech companies need to safeguard their networks against unanticipated disruptions. Here’s how.
A next-generation commercial model is needed fast. Those who adopt it quickly will be rewarded handsomely.
BCG Executive Perspectives offer insights on global topics that matter most to leaders in the public and private sectors. Our latest edition explores the evolving landscape of business and leisure travel, examining how companies within and beyond the industry can adapt to new trends.
What has worked, what can be improved, and what needs to be reimagined so that we are better prepared for the next pandemic and better able to improve health in the world’s poorest nations?
BCG Managing Director & Partner Johanna Benesty looks at barriers to "equitable access"—making sure COVID-19 therapeutics are available to all—while sharing a creative approach to vaccine research and development.